| Total Lymphoid Irradiation Pre-HSCT in Severe Congenital Neutropenia (NCT04844177) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2021-04-14 |
| Investigation of the Genetics of Hematologic Diseases (NCT02720679) | St. Jude Children's Research Hospital | 2016-06-17 |
| Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies (NCT02179359) | Masonic Cancer Center, University of Minnesota | 2014-09-02 |
| Bone Marrow Transplant With Abatacept for Non-Malignant Diseases (NCT01917708) | Emory University | 2014-01-01 |
| CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation (NCT01966367) | Diane George | 2013-03-01 |
| Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT01529827) | Roswell Park Cancer Institute | 2012-02-28 |
| Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation (NCT01319851) | Emory University | 2010-09-01 |
| Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease (NCT00295971) | University of California, San Francisco | 2005-04-01 |
| Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders (NCT00301834) | University of California, San Francisco | 2005-01-01 |
| Stem Cell Transplant for Hemoglobinopathy (NCT00176852) | Masonic Cancer Center, University of Minnesota | 2002-06-01 |
| Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission (NCT00305708) | University of California, San Francisco | 2000-08-01 |